References
- Tos M. Nasal polyps. Curr Opin Otolaryngol Head Neck Surg 1995; 3: 31–5.
- Larsen K, Tos M. A long-term follow-up study of nasal polyp patients after simple polypectomies. Eur Arch Otorhinolaryngol 1997; 254: 85–8.
- Folkman J. Clinical applications of research on angio-genesis. N Engl J Med 1995; 333: 1757–63.
- Ferrara N. Vascular endothelial growth factor: molecu-lar and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1–30.
- Veikkola T, Alitalo K. VEGFs, receptors and angiogen-esis. Cancer Biol 1999; 9: 211–20.
- Petruson B, Hansson H-A, Petruson K. Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps. Acta Otolaryngol (Stockh) 1988; 106: 156–60.
- Ohno I, Lea RG, Finotto S, et al. Granulocyte macro-phage colony-stimulating factor gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 1991; 5: 505–10.
- Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissue express transforming growth factor-beta 1 gene. J Clin Invest 1992; 89: 1662–8.
- Coste A, Wang QP, Roudot-Thoraval F, et al. Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 1996; 106: 578–83.
- Coste A, Wang QP, Lefaucheur JO, et al. Transforming growth factor-beta expression in inflammatory mucosa from upper airways. Am J Respir Crit Care Med 1996; 153: 636.
- Wang QP, Escudier E, Roudot-Thoraval F, Samad IAA, Peynegre R, Coste A. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 1997; 107: 926–31.
- Ishibashi T, Tanaka T, Nibu K, Ishimoto S, Kaga K. Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 1998; 107: 885–90.
- Powers MR, Qu Z, Lagesse PC, Liebler JM, Wall MA, Rosenbaum JT. Expression of basic fibroblast growth factor in nasal polyps. Ann Otol Rhinol Laryngol 1998; 107: 891–7.
- Norlander T, Westermark A, van Setten G, Valtonen H, Ishizaki H, Pyykko I. Basic fibroblast growth factor in nasal polyps. Immunohistochemical and quantitative findings. Rhinology 2001; 39: 88–92.
- Ito A, Hirota S, Mizuno H, et al. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Int 1995; 45: 715–20.
- Vento SL, Wolff CH, Salven PJ, Hytonen ML, Ertama LO, Malmberg CH. Vascular permeability factor/vas-cular endothelial growth factor in nasal polyps. Acta Otolaryngol Suppl 2000; 543: 170–4.
- Coste A, Brugel L, Maitre B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 2000; 15: 367–72.
- Wittekindt C, Hess A, Bloch W, Sultanie S, Michel O. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 2002; 259: 294–8.
- Ristimäki A, Narko K, Enholm B, et al. Pro-inflamma-tory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth fac-tor-C. J Biol Chem 1998; 273: 8413–8.
- Benson M, Carlsson B, Carlsson LMS, Wennergren G, Carden LO. Increased expression of vascular endothelial growth factor-A in seasonal allergic rhinitis. Cytokine 2002; 20: 268–73.
- Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107: 295–301.
- Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 1996; 17: 243–9.
- Baillie R, Harada K, Cathie J, Maclusky M, Schor SL, Schor AM. Expression of vascular endothelial growth factor in normal and tumour oral tissues assessed with different antibodies. Histochem J 2001; 33: 287–94.
- Neufeld G, Kessler O, Vadasz Z, Gluzman-Poltorak Z. The contribution of proangiogenic factors to the pro-gression of malignant disease: role of vascular endothe-lial growth factor and its receptors. Surg Oncol Clin N Am 2001; 10: 339–56.
- Cayé-Thomasen P, Baandrup L, Jacobsen GK, Thom-sen J, Stangerup SE. Immunohistochemical demonstration of VEGF in vestibular schwannomas correlates with tumour growth rate. Laryngoscope 2003; In press.